{
    "title": "Russia to roll out its first approved COVID-19 drug next week",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8376129/Russia-roll-approved-COVID-19-drug-week.html",
    "date": "2020-06-01",
    "keywords": [
        "drug",
        "dmitriev",
        "avifavir",
        "covid19",
        "russia",
        "june",
        "week",
        "health",
        "system",
        "head",
        "company",
        "month",
        "efficacy",
        "use",
        "healthcare",
        "share",
        "japan",
        "government",
        "process",
        "success",
        "death",
        "work",
        "moscow",
        "state",
        "backer",
        "move",
        "return",
        "life",
        "name",
        "wealth",
        "fund",
        "interview",
        "vaccine",
        "disease",
        "coronavirus",
        "gilead",
        "remdesivir",
        "promise",
        "compassionate",
        "emergency",
        "favipiravir",
        "fujifilm",
        "kirill",
        "avigan",
        "minister",
        "shinzo",
        "abe",
        "funding",
        "list",
        "saturday",
        "virus",
        "ministry",
        "approval",
        "manufacturing",
        "march",
        "control",
        "placebo",
        "earlystage",
        "guarantee",
        "study",
        "example",
        "hydroxychloroquine",
        "president",
        "risk",
        "game",
        "changer",
        "strain",
        "condition",
        "activity",
        "number",
        "world",
        "brazil",
        "toll",
        "something",
        "focus",
        "debate",
        "rdif",
        "manufacturer",
        "chemrar",
        "tune",
        "development",
        "macfie",
        "kate",
        "kelland"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}